SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-013922
Filing Date
2019-08-01
Accepted
2019-08-01 06:31:26
Documents
65
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 775231
2 EXHIBIT 10.12 ex10_12.htm EX-10.12 70543
3 EXHIBIT 10.13 ex10_13.htm EX-10.13 26310
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13199
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 13165
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 5034
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 4994
14 image0.jpg GRAPHIC 92911
15 image00001.jpg GRAPHIC 2255
  Complete submission text file 0001140361-19-013922.txt   4520690

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT pdsb-20190630.xml EX-101.INS 705605
9 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20190630.xsd EX-101.SCH 39420
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20190630_cal.xml EX-101.CAL 45161
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20190630_def.xml EX-101.DEF 158366
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20190630_lab.xml EX-101.LAB 596655
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20190630_pre.xml EX-101.PRE 322410
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 19990806
SIC: 2834 Pharmaceutical Preparations